Efficacy of Colchicine for Secondary Prevention of Stroke: A Systematic Review and Meta-Analysis of Randomized Control Trials
Godfrey Tabowei, Hafiza Faiza Rauf, Milan Dhungana, Muhammad Awais, Keron Blair, Sandipkumar S Chaudhari, Ihtisham Habib, Adil Amin · 2024
Read Efficacy of Colchicine for Secondary Prevention of Stroke: A Systematic Review and Meta-Analysis of Randomized Control Trials by Godfrey Tabowei, Hafiza Faiza Rauf, Milan Dhungana, Muhammad Awais, Keron Blair, Sandipkumar S Chaudhari, Ihtisham Habib, Adil Amin (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11706611.txt.
Description
Godfrey Tabowei and co-authors gather trial evidence in a 2024 review on whether an old anti-inflammatory drug, colchicine, can prevent a second stroke. The drug has long been used for gout and other inflammatory ills. New interest asks whether calming inflammation can also cut the risk of another stroke after a first one.
The team searched several databases up to November 2024 for randomized trials of the drug for stroke prevention. Two reviewers screened the studies, pulled the data, and judged quality with a standard bias tool on their own. They pooled the results to compare stroke rates and deaths from any cause between drug and control groups. The review gives doctors a single summary of benefit and safety for a cheap, widely known drug.
Catalog record
| CREATOR | Godfrey Tabowei, Hafiza Faiza Rauf, Milan Dhungana, Muhammad Awais, Keron Blair, Sandipkumar S Chaudhari, Ihtisham Habib, Adil Amin |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |